17th Annual Nanoscience & Nanotechnology Forum – NanoDay! 10/19/16 – Keynote Speaker – Mark Saltzman

September 14, 2016

Posted by Sarah Satterwhite

17th Annual Nanoscience and Nanotechnology Forum
Wednesday, October 19, 2016

A yearly forum for faculty, postdocs, and students engaged in nanoscience and nanotechnology research. 

1:00 – 1:10  Welcome Sandra Rosenthal, Director of VINSE
1:10 – 1:20  New Tool in VINSE: Helios FIB SEM Anthony Hmelo, VINSE
1:20 – 1:40  Ultrafast Vibrational Spectroscopies to Probe Systems at the Interface of Biology and NanotechnologyLauren Buchanan, Chemistry
1:40 – 2:00  Using Silicon Nanophotonics to Achieve Extreme Light-Matter Interaction Sharon Weiss, Electrical Engineering
2:00 – 2:20  Contact Thermal Resistance between Individual Carbon Nanotubes Deyu Li, Mechanical Engineering

2:25 – 3:10   POSTER SESSION
3:10 – 3:30   The Optoelectronic Properties of Ternary I-III-VI2 Semiconductor Nanocrystals and Their Hybrids Alice Leach, Graduate Student, Interdisciplinary Materials Science
3:30 – 3:50   Low-dimensional Materials for Optoelectronics and Bioelectronics Yaqiong Xu, Electrical Engineering
3:50 – 4:10   Polymeric siRNA Nanocarriers for Breast Cancer Therapy Craig Duvall, Biomedical Engineering
4:20 – 5:00   POSTER SESSION
5:00 – 6:00   KEYNOTE SPEAKER Polymer Nanoparticles for Drug Delivery, Gene Editing, and Cell Targeting W. Mark Saltzman, Biomedical Engineering, Yale University

Abstract. The primary goal of nanomedicine—using materials such as polymer nanoparticles—is to improve clinical outcomes. For example, targeted nanoparticles can be engineered to reduce non-productive distribution while improving diagnostic and therapeutic efficacy.  Paradoxically, as the field has matured, the notion of ‘targeting’ has been minimized to the concept of increasing affinity of a nanoparticle for its target, and most applications have focused on intravenous delivery, where this kind of targeting is most difficult to achieve. Here, I present examples of alternate approaches, in which nanoparticle design is used for treatment of brain tumors, targeted correction of a single-gene disorder, long-lasting, safe prevention of UV-mediated DNA damage in skin, and antibody-mediated targeting of inflamed endothelium. These examples all involve targeted nanoparticles, but with unique designs that guide their biological activity.

Bio. Mark Saltzman is an engineer and educator. Dr. Saltzman’s research in the fields of drug delivery, biomaterials, nanobiotechnology, and tissue engineering is described in over 250 research papers and 15 patents. He is the author of three textbooks: Biomedical Engineering (Second Edition, 2015), Tissue Engineering (2004), and Drug Delivery (2001).

The grandson of Iowa farmers, Mark Saltzman earned degrees in chemical engineering (B.S. Iowa State University 1981 and M.S. MIT 1984) and medical engineering (Ph.D. MIT 1987). He served on the faculty at Johns Hopkins (1987-1996), Cornell (1996-2002), where he was the first BP Amoco/H. Laurance Fuller Chair, and Yale, where he has been the Goizueta Foundation Professor since 2002. He was named the founding chair of the Yale’s Department of Biomedical Engineering in 2003, and served in that role until 2015.

Dr. Saltzman has been recognized for his excellence in research and teaching. He received the Mines Medal (2014); the Camille and Henry Dreyfus Foundation Teacher-Scholar Award (1990); the Allan C. Davis Medal (1995); the Controlled Release Society Young Investigator Award (1996); and the Professional Progress in Engineering Award from Iowa State University (2000). He has been elected a Fellow of the National Academy of Inventors (2014); Fellow of the American Institute for Medical and Biological Engineering (1997); a Fellow of the Biomedical Engineering Society (2010); a Member of the Connecticut Academy of Science & Engineering (2012); and a Member of the National Academy of Medicine (2014).

Dr. Saltzman has taught dozens of college courses including Heat & Mass Transfer, Material & Energy Balances, Engineering of Drug Delivery, Physiological Systems, and Molecular Transport & Intervention in the Brain. His course Frontiers of Biomedical Engineering is available to everyone through Open Yale Courses (http://oyc.yale.edu).

Research Interests

Drug Delivery
Gene Therapy
Tissue Engineering


Department of Biomedical Engineering  |  Yale University
Malone Engineering Center (map)
55 Prospect St.  |  New Haven, CT 06511

Vascular Biology & Therapeutics Program | Yale School of Medicine
Amistad Research Building (map)
10 Amistad St.  |  New Haven, CT 06520

For More Information

If you are interested in learning more about open positions in our lab, please e-mail Mark Saltzman.